The TP53 mutation in the DLBCL sample presumably resulted in biallelic inactivation of the gene, because the mutation was accompanied by a deletion in the TP53 locus, and the variant allele frequency (VAF) of the TP53 mutation was 74%. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.